Invention Grant
- Patent Title: Substituted 4-hydroxypyrimidine-5-carboxamides
- Patent Title (中): 取代的4-羟基嘧啶-5-甲酰胺
-
Application No.: US12381468Application Date: 2009-03-12
-
Publication No.: US08278304B2Publication Date: 2012-10-02
- Inventor: Matthew J. Clements , John S. Debenham , Jeffrey J. Hale , Christina B. Madsen-Duggan , Thomas F. Walsh
- Applicant: Matthew J. Clements , John S. Debenham , Jeffrey J. Hale , Christina B. Madsen-Duggan , Thomas F. Walsh
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: US NJ Rahway
- Agent Patricia A. Shatynski; Valerie J. Camara
- Main IPC: A61K31/501
- IPC: A61K31/501 ; A61K31/4965 ; C07D401/06 ; C07D239/02
Abstract:
The present invention relates to substituted 4-hydroxypyrimidine-5-carboxamides useful as HIF prolyl hydroxylase inhibitors to treat anemia and like conditions.
Public/Granted literature
- US20090239876A1 Substituted 4-Hydroxypyrimidine-5-Carboxamides Public/Granted day:2009-09-24
Information query
IPC分类:
